Metraipolis › archive › dc_80682be82ac0

What is the incidence and clinical significance of dry eye disease in patients treated with immune checkpoint inhibitors? A systematic review and… — Europe PMC PMID:41800487

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41800487
DOI
10.1111/aos.70058
License (as archived)
solo-consultazione
Archived
2026-11-05T00:09:44.069Z
SHA-256 of the archived text
9ac295dab7a52422581948e369ab64c6fc72df75328a49225db9ac64292b36a9
Stable URL of this page
https://metraipolis.com/documento/dc_80682be82ac0

How to cite

What is the incidence and clinical significance of dry eye disease in patients treated with immune checkpoint inhibitors? A systematic review and… — Europe PMC PMID:41800487 — Europe PMC (en), https://europepmc.org/article/MED/41800487 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_80682be82ac0 (Metraipolis archive dc_80682be82ac0, sha256 9ac295dab7a52422581948e369ab64c6fc72df75328a49225db9ac64292b36a9)
BibTeX
@misc{dc80682be82ac0,
  title = {What is the incidence and clinical significance of dry eye disease in patients treated with immune checkpoint inhibitors? A systematic review and… — Europe PMC PMID:41800487},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41800487},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_80682be82ac0; sha256 9ac295dab7a52422581948e369ab64c6fc72df75328a49225db9ac64292b36a9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41800487. Agents can read the archived copy with the MCP tool read_document.